Achieving sustained virological response after direct-acting antiviral therapy reduces liver-related events among those with decompensated HCV cirrhosis.
14d
This woman had to campaign to find a liver donor. Transplant docs say there should be a better way
It's pretty unusual in the medical system for a patient to be tasked with finding their own cure. But that’s what happened to Stephanie Azzarello in 2023 when she was told she needed a liver ...
Resolution Therapeutics Limited ("Resolution" or "Company"), a clinical-stage biopharmaceutical company pioneering Regenerative Macrophage Therapy (RMT) in inflammatory and fibrotic diseases, today ...
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative ...
Aldeyra Therapeutics reports positive results from phase 2 clinical trial in alcohol-connected hepatitis: Lexington, Massachusetts Thursday, October 30, 2025, 17:30 Hrs [IST] Alde ...
Pharmaceutical Technology on MSN
Aldeyra reshuffles pipeline, culling asset despite Phase II success
Despite ADX-629 meeting all its endpoints in a Phase II trial, Aldeyra is culling the asset as part of a pipeline ...
A Kelowna woman whose fraught journey to get to the top of the liver transplant list has received some political support.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback